Skip to main content
Clinical Trials/DRKS00009427
DRKS00009427
Completed
Not Applicable

The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets. - PROPAG-AGEING - Phase 1

IRCCS Istituto delle Scienze Neurologiche di Bologna0 sites15,900 target enrollmentOctober 22, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G20
Sponsor
IRCCS Istituto delle Scienze Neurologiche di Bologna
Enrollment
15900
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2015
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
IRCCS Istituto delle Scienze Neurologiche di Bologna

Eligibility Criteria

Inclusion Criteria

  • For PD patients:
  • 1\. Male and female patients older than 18 years;
  • For healthy controls:
  • 1\. Male and female patients older than 18 years;
  • 2\. Adhesion to the study after signature of a written informed consent.
  • For long\-lived subjects:
  • 1\. Subjects \>100 years old
  • 2\. Siblings \>90 years old

Exclusion Criteria

  • For PD patients:
  • 1\. Patients with parkinsonian syndromes with different etiology (cerebro\-vascular diseases, iatrogenic, infective, malformative or metabolic);
  • For healthy controls:
  • 1\. Subjects affected by cardiovascular diseases (coronary heart diseases, previous coronary stenting implantations..);
  • 2\. Subjects affected by psychiatric disorders;
  • 3\. Subjects affected by systemic, kidney, liver, or pulmonary diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials